From: Case-finding for alpha1-antitrypsin deficiency in Kazakh patients with COPD
 | PIMZ | PIMS | PIMI | Total |
---|---|---|---|---|
N | 3 | 1 | 2 | 6 |
Age (years) ÷ mean (SD) | 59(16.9) | 62 | 51(2) | 56.8(12.7) |
Male % | 33.3 | 100 | 50 | 50 |
BMI (kg/m2) ÷ mean (SD) | 22.7(0,9) | 18 | 25(2.5) | 21.2(2.3) |
FEV1/FVC ÷ mean (SD) | 0.48(0.2) | 0.34 | 0.48(0.02) | 0.47(0.6) |
FEV1% Predicted ÷ mean (SD) | 46.5(2.1) | 40 | 48.5(0.7) | 48(4.5) |
FVC(%) ÷ mean (SD) | 51.3(4.05) | 47 | 49.5(3.5) | 2.9(0.2) |
MRC (score) ÷ mean (SD) | 2 | 3 | 2 | 2.3 (0.5) |
CAT (score) ÷ mean (SD) | 29.5(2.1) | 40 | 34.5(6.3) | 34.3 (9.9) |
Current/former/non smoker (%) | 0/33,3/0 | 0/0/0 | 50/0/0 | 16,6/16,6/0 |
Pack/year ÷ (years) mean (SD) | 20 | 0 | 34 | 27(7) |